Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone
Clinical trial NCT04255576 · UNKNOWN
Trial details
- NCT number
- NCT04255576
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-10
- Primary completion
- 2023-09-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.